Search by CAS No , Chemical Name or Molecular Formula
"Furosemide, sold under the brand name Lasix among others, is a medication used to treat fluid build-up due to heart failure, liver scarring, or kidney disease. It may also be used for the treatment of high blood pressure. The amount of medication required depends on the person in question. It can be taken intravenously or by mouth. When taken by mouth it typically begins working within an hour while intravenously it typically begins working within five minutes.
Common side effects include low blood pressure with standing, ringing in the ears, and sensitivity to the sun. Potentially serious side effects include electrolyte abnormalities, low blood pressure, and hearing loss. Blood tests are recommended regularly for those on treatment. Furosemide is a type of loop diuretic that works by decreasing the reabsorption of sodium by the kidneys.
Furosemide was discovered in 1962. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale price in the developing world is between 0.004 and 0.02 USD per day. In the United States it is available as a generic medication and costs about 0.15 USD per day. Furosemide is on the World Anti-Doping Agency's banned drug list due to concerns that it may mask other drugs. It has also been used to prevent and treat race horses for exercise-induced pulmonary hemorrhage.",""
Impurity in commercial preparations of Furosemide
Goldenthal, E.I.: Toxcol. Appl. Pharmcol., 18, 185 (1971), Benet, L.Z.: J. Pharmcokinet. Biopharm., 7, 1 (1979)
We normally respond within 8 hours.
This page contains information about Furosemide EP impurity A Cas # 4818-59-1 and its Impurities.
Furosemide EP impurity A Furosemide EP impurity A Worldwide Suppliers of Furosemide EP impurity A https://www.clearsynth.com/en/CSO07842.html Impurities Clearsynth 4818-59-1
Product rating: 9 Furosemide EP impurity A based on 20 ratings
Keywords: Impurities CS-O-07842 Furosemide EP impurity A Furosemide 4818-59-1 330.74 C12H1ClN2O5S
Internal standard, Internal standard Furosemide, HPLC-MS method validation, HPLC-MS method validation Furosemide, LC-MS-MS method validation, LC-MS-MS method validation Furosemide, Deuterated internal standard, Deuterated internal standard Furosemide, Deuterated Furosemide, Deuterium labeled Furosemide, Quantitative bioanalytical methods, Quantitative bioanalytical methods Furosemide, Blood samples Furosemide, Blood concentrations, Heavy drugs, Analysis, Analysis Furosemide, Clinical diagnostic, Clinical diagnostic Furosemide, Dosing Furosemide, Analytical method development, Internal standard method.
CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060
CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
T : +91-40-27155481
CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
T : +91-22-45045945